Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Abigail Sharp
Institutions:
Cancer Research UK,
University College London
Observed institutions:
Cancer Research UK,
University College London
ORCID:
0009-0002-0721-3095
Observed ORCID:
0009-0002-0721-3095
OpenAlex ID:
A5076694083
Lung adenocarcinoma promotion by air pollutants
2023
·
William Hill
, Emilia L. Lim
, et al.
·
Nature
·
923
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
2023
·
Christopher Abbosh
, Alexander M. Frankell
, et al.
·
Nature
·
452
The evolution of lung cancer and impact of subclonal selection in TRACERx
2023
·
Alexander M. Frankell
, Michelle Dietzen
, et al.
·
Nature
·
380
PDF
The evolution of non-small cell lung cancer metastases in TRACERx
2023
·
Maise Al Bakir
, Ariana Huebner
, et al.
·
Nature
·
296
PDF
RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
2023
·
Kevin W. Ng
, Jesse Boumelha
, et al.
·
Nature
·
270
PDF
Genomic–transcriptomic evolution in lung cancer and metastasis
2023
·
Carlos Martínez-Ruiz
, James R. M. Black
, et al.
·
Nature
·
243
PDF
Body composition and lung cancer-associated cachexia in TRACERx
2023
·
Othman Al-Sawaf
, Jakob Weiss
, et al.
·
Nature Medicine
·
166
PDF
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer
2022
·
Yin Wu
, Dhruva Biswas
, et al.
·
Nature Cancer
·
140
PDF
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
2025
·
James R. M. Black
, Gabor Bartha
, et al.
·
Nature Medicine
·
130
PDF
Evolutionary characterization of lung adenocarcinoma morphology in TRACERx
2023
·
Takahiro Karasaki
, David A. Moore
, et al.
·
Nature Medicine
·
126
PDF
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
2020
·
Ehsan Ghorani
, James L. Reading
, et al.
·
Nature Cancer
·
101
Using DNA sequencing data to quantify T cell fraction and therapy response
2021
·
Robert Bentham
, Kevin Litchfield
, et al.
·
Nature
·
68
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling
2024
·
Sebastijan Hobor
, Maise Al Bakir
, et al.
·
Nature Communications
·
58
PDF
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma
2024
·
Xiaoxi Pan
, Khalid AbdulJabbar
, et al.
·
Nature Cancer
·
58
PDF
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models
2024
·
Robert E. Hynds
, Ariana Huebner
, et al.
·
Nature Communications
·
40
PDF
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx
2024
·
Alexander M. Frankell
, Michelle Dietzen
, et al.
·
Nature
·
7
PDF
STATEC: A randomised trial of non-selective versus selective adjuvant therapy in high risk apparent stage 1 endometrial cancer.
2018
·
Tim Mould
, Alison Brand
, et al.
·
Journal of Clinical Oncology
·
5
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
2020
·
Francesca Chemi
, Dominic G. Rothwell
, et al.
·
Nature Medicine
·
3
PDF
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer
2020
·
Kroopa Joshi
, Marc Robert de Massy
, et al.
·
Nature Medicine
·
2
PDF
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
2026
·
Kevin W. Ng
, Jesse Boumelha
, et al.
·
Nature
PDF
Show more works
View as search
Works count:
20
Citation count:
3,468
H-index:
15
I10-index:
15
Year
Topic
Type